Vision Care Market
Medical Device

Vision Care Market is Emerging with 4.5% of CAGR by 2028

Vision care products include eye glasses, contact lens, intraocular lens, contact lens solution, eye drops and others. Increasing number of eye disorders have led to the development of advanced vision care products. Also, increasing vision care awareness programs have increased the adoption of vision care products.

Essilorluxottica SA and. Alcon Inc.Notable Participants in Vision Care Market

A few of the most notable companies occupying a considerable share of the market are Alcon Inc, Bausch Health Companies Inc, Carl Zeiss AG, Cooper Companies Inc, Essilorluxottica SA, Johnson And Johnson Services Inc., Hoya Corporation, Rodenstock Gmbh, Menicon Co. Ltd, Rayner Intraocular Lenses Limited.

Market leaders are involved in partnerships, product launches, acquisitions, and other strategies to improve their performance and consolidate the market position. For instance, in January 2021 Alcon Inc. launched its first and only non-diffractive extended depth of focus intraocular lens (IOL), the AcrySof IQ VivityT IOL (Vivity), in the US. This new lens is now available to all ophthalmologists for patients undergoing cataract surgery in the US.

Prominent players in the Vision Care market are focusing on organic strategies such as product launches, product approvals, and geographic and manufacturing expansions. These strategies help them strengthen their market positions, along with allowing them to broaden their geographic footprints. Additionally, various companies are undertaking acquisitions to garner their significance and remain competitive in the market. A few of the vital developments in the vision care market are mentioned below:

Year

News

Region

2021

The company received CE Mark for its multifocal contact lens, Acuvue Oasys multifocal with pupil optimized design for Europe. it will be used for patients with presbyopia.

Europe

2021

The company received FDA approval for the TECNIS Eyhance, and TECNIS EyhanceTM Toric II intraocular lens (IOL) for the treatment of cataract patients in the US.

America